Hepatitis B
📧 Sign up to get email alerts when something new happens for Hepatitis B.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-02-28Clinical Trial Update: A Double-Blind Single-Ascending Dose (SAD) and Multiple-Ascending Dose (MAD) Study to Investigate the Safety, Tolerability, and Pharmacokinetics of RO7049389 in Healthy Chinese Participants [Phase 1]
Phase 1 SAD/MAD study in healthy Chinese participants evaluating safety, tolerability, and pharmacokinetics of RO7049389.
-
CLINICAL_TRIALS trial_result · 2020-02-18Clinical Trial Update: Peg-interferon ADDed to an Ongoing Nucleos(t)Ide Based Treatment in Patients With Chronic Hepatitis B to Induce Decrease of HBs-Antigen [Phase 2]
Phase 2 trial investigating addition of peg-interferon to nucleos(t)ide-based therapy in chronic hepatitis B to reduce HBs antigen; complete…
-
CLINICAL_TRIALS trial_result · 2020-02-17Clinical Trial Update: Maintaining Antiviral Efficacy After Switching to Generic Entecavir 1 mg for Chronic Hepatitis B [Phase 4]
Phase 4 trial update examining maintaining antiviral efficacy after switching to generic entecavir 1 mg for chronic hepatitis B.
-
CLINICAL_TRIALS trial_result · 2020-02-12Clinical Trial Update: The Relationship Between Vitamin D and Hepatitis B Virus Replication [NA]
A completed clinical trial assessing the relationship between vitamin D and hepatitis B virus replication, with results posted in 2020.
-
CLINICAL_TRIALS research · 2020-02-11Clinical Trial Update: A Study Evaluating the Safety, Pharmacokinetics, and Antiviral Efficacy of SB 9200 in Subjects Infected With Chronic HBV [Phase 2]
APhase 2 clinical trial evaluating safety, pharmacokinetics, and antiviral efficacy of SB 9200 in subjects with chronic hepatitis B.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: Prophylaxis of CHB Patients With Malignant Tumor Receiving Chemotherapy [Phase 4]
Phase 4 clinical trial update on prophylaxis for chronic hepatitis B patients with malignant tumors receiving chemotherapy.
-
FDA approval · 2020-02-04FDA Approved: VEMLIDY — Supplemental Application (Gilead Sciences, Inc.)
FDA approved a supplemental application for Vemlidy (tenofovir alafenamide) submitted by Gilead Sciences.
-
CLINICAL_TRIALS trial_result · 2020-01-30Clinical Trial Update: HBV-associated Liver Transplant(LT) Patients by IV Injecting GC1102 [Phase 2, Phase 3]
Phase 2/Phase 3 clinical trial update for GC1102 in HBV-associated liver transplant patients.
-
CLINICAL_TRIALS trial_result · 2020-01-27Clinical Trial Update: Phase 3 and Extensional Study of Besifovir [Phase 3]
Phase 3 trial update and extension study for Besifovir in chronic hepatitis B.
-
CLINICAL_TRIALS trial_result · 2020-01-22Clinical Trial Update: A Study to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK3389404 in Chronic Hepatitis B (CHB) Subjects [Phase 2]
Phase 2 clinical trial assessing safety, tolerability, PK, and PD of GSK3389404 in chronic hepatitis B has completed; results posted in 2020…
-
CLINICAL_TRIALS trial_result · 2020-01-14Clinical Trial Update: Evaluation of Immunogenicity and Safety of a Booster Dose of Infanrix Hexa™ in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery [Phase 4]
Phase 4 trial evaluating immunogenicity and safety of a booster dose of Infanrix Hexa in healthy infants born to mothers vaccinated with Boo…
-
FDA approval · 2020-01-07FDA Approved: TENOFOVIR DISOPROXIL FUMARATE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental ANDA for Tenofovir disoproxil fumarate from Macleods Pharmaceuticals Limited, authorizing a supplemental approva…
-
CLINICAL_TRIALS trial_result · 2020-01-06Clinical Trial Update: Immunogenicity & Safety Study of Combined/Separate Vaccine(s) Against Common Diseases in Infants (2,4,6 Months of Age). [Phase 3]
Phase 3 immunogenicity and safety trial evaluating combined or separate vaccines against common childhood diseases in infants (2, 4, 6 month…
-
CLINICAL_TRIALS research · 2020-01-02Clinical Trial Update: A Study of Switching From Entecavir to Tenofovir Disoproxil Fumarate in Subjects With Chronic Hepatitis B [Phase 4]
A Phase 4 clinical trial comparing switching from entecavir to tenofovir disoproxil fumarate in adults with chronic hepatitis B has complete…
-
CLINICAL_TRIALS trial_result · 2019-12-30Clinical Trial Update: A Multicenter, Open-label, Randomized Clinical Study to Assess Efficacy and Safety of 3 Doses of Myrcludex B for 24 Weeks in Combination With Tenofovir Compared to Tenofovir Alone to Suppress HBV Replication in Patients With Chronic Hepatitis D [Phase 2]
Phase 2 randomized study evaluating three dosing regimens of Myrcludex B with tenofovir versus tenofovir alone for chronic hepatitis D; stud…
-
CLINICAL_TRIALS trial_result · 2019-12-19Clinical Trial Update: Combination of ETV, TQ-A3334 and TQ-B2450 for CHB (Neptune Study) [Phase 2]
A Phase 2 clinical trial update on a combination of ETV, TQ-A3334, and TQ-B2450 for chronic hepatitis B is in progress, with the status curr…
-
CLINICAL_TRIALS trial_result · 2019-12-17Clinical Trial Update: Switching From Tenofovir Disoproxil Fumarate to Besifovir Dipivoxil Maleate [Phase 4]
A Phase 4 clinical trial update evaluating switching from tenofovir disoproxil fumarate to besifovir dipivoxil maleate for hepatitis B treat…
-
CLINICAL_TRIALS trial_result · 2019-12-16Clinical Trial Update: A Study of TQ-A3334 Combined With Entecavir in the Treatment of Chronic Hepatitis B [Phase 2]
A Phase 2 clinical trial evaluating TQ-A3334 in combination with entecavir for Chronic Hepatitis B.
-
FDA approval · 2019-12-13FDA Approved: TENOFOVIR DISOPROXIL FUMARATE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Tenofovir disoproxil fumarate from Aurobindo Pharma Limited. The approval covers this generic fo…
-
CLINICAL_TRIALS trial_result · 2019-12-13Clinical Trial Update: A Study of GC1102(Recombinant Hepatitis B Immunoglobulin) in Chronic Hepatitis B Patients [Phase 2]
Phase 2 clinical trial update for GC1102 recombinant hepatitis B immunoglobulin in chronic hepatitis B patients.
-
CLINICAL_TRIALS trial_result · 2019-12-12Clinical Trial Update: Tenofovir to Prevent HBV Reactivation [Phase 3]
Phase 3 clinical trial update on using tenofovir to prevent hepatitis B reactivation in patients with hematologic malignancies.
-
CLINICAL_TRIALS trial_result · 2019-12-12Clinical Trial Update: Tenofovir Disoproxil Fumarate in Combination of Hepatitis B Vaccine for Preventing Hepatitis B Vertical Transmission [Phase 4]
Phase 4 trial investigating Tenofovir Disoproxil Fumarate in combination with hepatitis B vaccine to prevent vertical transmission of hepati…
-
CLINICAL_TRIALS trial_result · 2019-12-09Clinical Trial Update: Tenofovir in Late Pregnancy to Prevent Vertical Transmission of Hepatitis B Virus [Phase 4]
Phase 4 clinical trial assessing teneofovir in late pregnancy to reduce vertical transmission of hepatitis B.
-
CLINICAL_TRIALS trial_result · 2019-11-12Clinical Trial Update: An Study to Evaluate Safety and Efficacy of QL-007 Tablets in Combination With Tenofovir in Naive Patients With Chronic Hepatitis b [Phase 2]
Phase 2 trial evaluating safety and efficacy of QL-007 tablets in combination with Tenofovir for treatment-naive chronic hepatitis B patient…
-
CLINICAL_TRIALS trial_result · 2019-11-08Clinical Trial Update: PEG-interferon Alfa-2a add-on Study in HBeAg Negative Chronic Hepatitis B Patients [Phase 4]
Phase 4 clinical trial update evaluating PEG-interferon alfa-2a as an add-on in HBeAg-negative chronic hepatitis B patients.